AL-54478 Proof of Concept Study

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the safety and efficacy of AL-54478 0.005% compared with Latanoprost 0.005% and AL-54478 Vehicle in patients with open-angle glaucoma or ocular hypertension.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01318252
Study type	Interventional
Source	Alcon Research
Contact
Status	Completed
Phase	Phase 2
Start date	June 2011
Completion date	October 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02565173` - Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma	Phase 3
Terminated	`NCT02226094` - Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension	Phase 1/Phase 2
Recruiting	`NCT06016972` - Qlaris Phase 2 Study of QLS-111 in POAG and/or OHT Patients	Phase 2
Terminated	`NCT01180062` - Safety Study of Latanoprost Slow Release Insert	Phase 1
Completed	`NCT01917383` - A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma	Phase 2
Completed	`NCT01670266` - Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma	Phase 1
Completed	`NCT02829996` - Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG	Phase 2
Recruiting	`NCT06249152` - Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients	Phase 2